台湾地区白细胞介素-12A 和白细胞介素-12B 基因型对大肠癌的影响。

IF 1.7 4区 医学 Q4 ONCOLOGY Anticancer research Pub Date : 2025-04-01 DOI:10.21873/anticanres.17532
Te-Cheng Yueh, Ying-Jing Chen, Mei-Chin Mong, Tao-Wei Ke, Hou-Yu Shih, Yun-Chi Wang, Wen-Shin Chang, DA-Tian Bau, Chia-Wen Tsai
{"title":"台湾地区白细胞介素-12A 和白细胞介素-12B 基因型对大肠癌的影响。","authors":"Te-Cheng Yueh, Ying-Jing Chen, Mei-Chin Mong, Tao-Wei Ke, Hou-Yu Shih, Yun-Chi Wang, Wen-Shin Chang, DA-Tian Bau, Chia-Wen Tsai","doi":"10.21873/anticanres.17532","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Interleukin-12 (IL12) plays a crucial role in immune regulation and inflammation and is critical in developing colorectal cancer (CRC). This study investigated the association between <i>IL12A</i> rs568408, <i>IL12A</i> rs2243115, and <i>IL12B</i> rs3212227 polymorphisms and CRC susceptibility in a Taiwanese population.</p><p><strong>Materials and methods: </strong>Genotypic and allelic distributions were analyzed in 362 non-cancer controls and patients with CRC <i>via</i> restriction fragment length polymorphism methods.</p><p><strong>Results: </strong>All three polymorphisms fit well to the Hardy-Weinberg equilibrium (<i>p</i>>0.05). The frequencies of <i>IL12A</i> rs568408 GG, AG and AA genotypes were 73.5%, 22.9% and 3.6% in CRC cases, compared to 76.8%, 20.7%, and 2.5% in controls (<i>p</i> for trend=0.4973). No significant associations were observed for AG [odds ratio (OR)=1.16, 95% confidence interval (CI)=0.81-1.65, <i>p</i>=0.4752] or AA (OR=1.51, 95% CI=0.63-3.59, <i>p</i>=0.4715) genotypes. Dominant and recessive models showed no significant correlation (OR=1.22, 95% CI=0.87-1.71, <i>p</i>=0.2845; and OR=1.46, 95% CI=0.62-3.46, <i>p</i>=0.5160, respectively). Similarly, <i>IL12A</i> rs2243115 and <i>IL12B</i> rs3212227 genotypic distributions were comparable between cases and controls (<i>p</i> for trend=0.7209 and 0.5997, respectively). Allelic analysis further confirmed the lack of significant association: <i>IL12A</i> rs568408 A allele: OR=1.20, 95% CI=0.89-1.62, <i>p</i>=0.2552; <i>IL12A</i> rs2243115 G allele: OR=0.91, 95% CI=0.63-1.33, <i>p</i>=0.7019; and <i>IL12B</i> rs3212227 C allele: OR=0.90, 95% CI=0.73-1.10, <i>p</i>=0.3174.</p><p><strong>Conclusion: </strong>These findings suggest that <i>IL12A</i> and <i>IL12B</i> polymorphisms are not significantly associated with CRC susceptibility in the Taiwanese population. Future research should explore other <i>IL12A</i> and <i>IL12B</i> polymorphisms, gene-gene and gene-phenotype interactions, and the role of IL12' in immune regulation, which may offer insights for clinical applications and therapies.</p>","PeriodicalId":8072,"journal":{"name":"Anticancer research","volume":"45 4","pages":"1501-1512"},"PeriodicalIF":1.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal Cancer in Taiwan.\",\"authors\":\"Te-Cheng Yueh, Ying-Jing Chen, Mei-Chin Mong, Tao-Wei Ke, Hou-Yu Shih, Yun-Chi Wang, Wen-Shin Chang, DA-Tian Bau, Chia-Wen Tsai\",\"doi\":\"10.21873/anticanres.17532\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>Interleukin-12 (IL12) plays a crucial role in immune regulation and inflammation and is critical in developing colorectal cancer (CRC). This study investigated the association between <i>IL12A</i> rs568408, <i>IL12A</i> rs2243115, and <i>IL12B</i> rs3212227 polymorphisms and CRC susceptibility in a Taiwanese population.</p><p><strong>Materials and methods: </strong>Genotypic and allelic distributions were analyzed in 362 non-cancer controls and patients with CRC <i>via</i> restriction fragment length polymorphism methods.</p><p><strong>Results: </strong>All three polymorphisms fit well to the Hardy-Weinberg equilibrium (<i>p</i>>0.05). The frequencies of <i>IL12A</i> rs568408 GG, AG and AA genotypes were 73.5%, 22.9% and 3.6% in CRC cases, compared to 76.8%, 20.7%, and 2.5% in controls (<i>p</i> for trend=0.4973). No significant associations were observed for AG [odds ratio (OR)=1.16, 95% confidence interval (CI)=0.81-1.65, <i>p</i>=0.4752] or AA (OR=1.51, 95% CI=0.63-3.59, <i>p</i>=0.4715) genotypes. Dominant and recessive models showed no significant correlation (OR=1.22, 95% CI=0.87-1.71, <i>p</i>=0.2845; and OR=1.46, 95% CI=0.62-3.46, <i>p</i>=0.5160, respectively). Similarly, <i>IL12A</i> rs2243115 and <i>IL12B</i> rs3212227 genotypic distributions were comparable between cases and controls (<i>p</i> for trend=0.7209 and 0.5997, respectively). Allelic analysis further confirmed the lack of significant association: <i>IL12A</i> rs568408 A allele: OR=1.20, 95% CI=0.89-1.62, <i>p</i>=0.2552; <i>IL12A</i> rs2243115 G allele: OR=0.91, 95% CI=0.63-1.33, <i>p</i>=0.7019; and <i>IL12B</i> rs3212227 C allele: OR=0.90, 95% CI=0.73-1.10, <i>p</i>=0.3174.</p><p><strong>Conclusion: </strong>These findings suggest that <i>IL12A</i> and <i>IL12B</i> polymorphisms are not significantly associated with CRC susceptibility in the Taiwanese population. Future research should explore other <i>IL12A</i> and <i>IL12B</i> polymorphisms, gene-gene and gene-phenotype interactions, and the role of IL12' in immune regulation, which may offer insights for clinical applications and therapies.</p>\",\"PeriodicalId\":8072,\"journal\":{\"name\":\"Anticancer research\",\"volume\":\"45 4\",\"pages\":\"1501-1512\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anticancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/anticanres.17532\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anticancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/anticanres.17532","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:白细胞介素-12 (il -12)在免疫调节和炎症中起重要作用,在结直肠癌(CRC)的发生中起关键作用。本研究探讨台湾人群中IL12A rss568408、IL12A rs2243115和IL12B rs3212227多态性与结直肠癌易感性之间的关系。材料与方法:采用限制性片段长度多态性方法分析362例非癌对照和结直肠癌患者的基因型和等位基因分布。结果:三个多态性均符合Hardy-Weinberg平衡(p < 0.05)。IL12A rs568408 GG、AG和AA基因型的频率在CRC病例中分别为73.5%、22.9%和3.6%,而在对照组中分别为76.8%、20.7%和2.5% (p趋势=0.4973)。AG[比值比(OR)=1.16, 95%可信区间(CI)=0.81-1.65, p=0.4752]和AA (OR=1.51, 95% CI=0.63-3.59, p=0.4715)基因型无显著相关性。显性和隐性模型无显著相关性(OR=1.22, 95% CI=0.87-1.71, p=0.2845;OR=1.46, 95% CI=0.62-3.46, p=0.5160)。同样,IL12A rs2243115和IL12B rs3212227基因型分布在病例和对照组之间具有可比性(趋势p分别为0.7209和0.5997)。等位基因分析进一步证实两者间无显著相关性:IL12A rs568408 A等位基因:OR=1.20, 95% CI=0.89-1.62, p=0.2552;IL12A rs2243115 G等位基因:OR=0.91, 95% CI=0.63 ~ 1.33, p=0.7019;IL12B rs3212227 C等位基因:OR=0.90, 95% CI=0.73 ~ 1.10, p=0.3174。结论:在台湾人群中,IL12A和IL12B多态性与结直肠癌易感性无显著相关。未来的研究应进一步探索IL12A和IL12B的其他多态性、基因-基因和基因-表型的相互作用,以及IL12'在免疫调节中的作用,为临床应用和治疗提供新的思路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal Cancer in Taiwan.

Background/aim: Interleukin-12 (IL12) plays a crucial role in immune regulation and inflammation and is critical in developing colorectal cancer (CRC). This study investigated the association between IL12A rs568408, IL12A rs2243115, and IL12B rs3212227 polymorphisms and CRC susceptibility in a Taiwanese population.

Materials and methods: Genotypic and allelic distributions were analyzed in 362 non-cancer controls and patients with CRC via restriction fragment length polymorphism methods.

Results: All three polymorphisms fit well to the Hardy-Weinberg equilibrium (p>0.05). The frequencies of IL12A rs568408 GG, AG and AA genotypes were 73.5%, 22.9% and 3.6% in CRC cases, compared to 76.8%, 20.7%, and 2.5% in controls (p for trend=0.4973). No significant associations were observed for AG [odds ratio (OR)=1.16, 95% confidence interval (CI)=0.81-1.65, p=0.4752] or AA (OR=1.51, 95% CI=0.63-3.59, p=0.4715) genotypes. Dominant and recessive models showed no significant correlation (OR=1.22, 95% CI=0.87-1.71, p=0.2845; and OR=1.46, 95% CI=0.62-3.46, p=0.5160, respectively). Similarly, IL12A rs2243115 and IL12B rs3212227 genotypic distributions were comparable between cases and controls (p for trend=0.7209 and 0.5997, respectively). Allelic analysis further confirmed the lack of significant association: IL12A rs568408 A allele: OR=1.20, 95% CI=0.89-1.62, p=0.2552; IL12A rs2243115 G allele: OR=0.91, 95% CI=0.63-1.33, p=0.7019; and IL12B rs3212227 C allele: OR=0.90, 95% CI=0.73-1.10, p=0.3174.

Conclusion: These findings suggest that IL12A and IL12B polymorphisms are not significantly associated with CRC susceptibility in the Taiwanese population. Future research should explore other IL12A and IL12B polymorphisms, gene-gene and gene-phenotype interactions, and the role of IL12' in immune regulation, which may offer insights for clinical applications and therapies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Anticancer research
Anticancer research 医学-肿瘤学
CiteScore
3.70
自引率
10.00%
发文量
566
审稿时长
2 months
期刊介绍: ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies). Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.
期刊最新文献
Biological Features of Gastric Cancer After Neoadjuvant Chemotherapy. Short-term Outcomes of Robotic-assisted Versus Laparoscopic Right Hemicolectomy for Right-sided Colon Cancer: A Retrospective Study. TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma. Clinical Predictors of Neoadjuvant Chemotherapy Efficacy in Esophageal Squamous Cell Carcinoma. Study on the Synthesis and Structure-activity Relationship of 3-Styrylflavones Possessing Variously Hydroxylated D-ring Moiety.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1